Cosmos Health Inc.

AI-generated fair value estimate for this company.

Method: 10-year normalized-earnings DCF: $1.47M normalized base (assumes a 2% net margin achieved on $73.7M TTM revenue versus actual trailing net losses); 5% annual growth years 1-5; 3% years 6-10; 16% discount rate for going-concern/liquidity risk; 3% terminal growth; -$14.2M net debt ($1.8M cash less $16.0M debt); 100.63M shares outstanding.

Reasoning: Cosmos Health has persistent losses, minimal cash ($1.8M) against $16.0M of debt, and going-concern-level liquidity risk, so even an optimistic path to thin profitability is overwhelmed by net debt and share count, implying negligible per-share intrinsic value today.